What's in Biotech Pharmaceutical Co., Ltd.'s pipeline?

Biotech Pharmaceutical Co., Ltd. has 6 drugs in our index: 2 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Biotech Pharmaceutical Co., Ltd.'s portfolio?

Top competitors by shared drug class: Air Force Military Medical University, China, Akeso, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Central European Society for Anticancer Drug Research, Chengdu Kanghong Biotech Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/biotech-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Biotech Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief

Biotech Pharmaceutical Co., Ltd. pipeline: 2 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 3 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Nimotuzumab Injection	Nimotuzumab Injection	marketed	EGFR inhibitor monoclonal antibody	EGFR (Epidermal Growth Factor Receptor)	Oncology
painkiller	painkiller	marketed			Pain
placebo plus chemoradiotherapy	placebo plus chemoradiotherapy	phase 3			Oncology
placebo plus paclitaxel	placebo plus paclitaxel	phase 3	Taxane	Microtubules	Oncology
nimotuzumab plus paclitaxel	nimotuzumab plus paclitaxel	phase 3	Monoclonal antibody and taxane	EGFR	Oncology

Therapeutic area mix

Oncology · 4
Pain · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Air Force Military Medical University, China · 1 shared drug class
Akeso · 1 shared drug class
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · 1 shared drug class
Central European Society for Anticancer Drug Research · 1 shared drug class
Chengdu Kanghong Biotech Co., Ltd. · 1 shared drug class
El Kendi Pharmaceuticals Manufacturing Company · 1 shared drug class
Fourth Affiliated Hospital of Guangxi Medical University · 1 shared drug class
AbbVie (prior sponsor, Abbott) · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Biotech Pharmaceutical Co., Ltd.:

Cite this brief

Drug Landscape (2026). Biotech Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/biotech-pharmaceutical-co-ltd. Accessed 2026-05-16.